Monitoring of blood glucose levels in diabetics
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) the normal population and people with typical symptoms of diabetes; 2) age: all ages except newborn infants; 3) gender: no limit; 4) the blood glucose test was performed in the outpatient and inpatient patients, and the venous blood was extracted for other tests, and the measured values were in the measurable range.Select some samples with hypertension and hyperlipidemia; 5) patients voluntarily participate in clinical trials and sign informed consent.
Exclusion criteria
Exclusion criteria: 1) samples of anticoagulants with EDTA and heparin were used; 2) the range of hematocrit is over 20%~65%; 3) high levels of acetaminophen, uric acid, ascorbic acid (vitamin C) and other reductive substances in the samples; 4) the triglyceride in the blood sample was higher than 3000mg/dL, 33.9mmol/L or cholesterol was higher than 500mg/dL or 12.95mmol/L; 5) Samples of patients with hypotension and shock; 6) sample of patients with ketosis; 7) samples of patients in the dehydration state; 8) samples that exceed the range of test reagents, sample size, contaminated samples and samples with no clinical ID number should be excluded; 9) serious mental illness or other conditions cause the patient to be unable to sign informed consent and uncooperative patients.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| SPE, SEN, ACC; | — |
Countries
China
Contacts
Beijing traditional medicine hospital affiliated to capital medical university